{"DataElement":{"publicId":"7595953","version":"1","preferredName":"Mesothelioma Pathologic Finding Type","preferredDefinition":"Text term representing the additional pathologic findings related to mesothelioma.","longName":"7592031v1.0:7595756v1.0","context":"OCG","contextVersion":"1","DataElementConcept":{"publicId":"7592031","version":"1","preferredName":"Mesothelioma Investigation Finding Pathologic","preferredDefinition":"A usually malignant and aggressive neoplasm of the mesothelium which is often associated with exposure to asbestos._The result of an examination or inquiry._Caused by or altered by or manifesting disease or pathology.","longName":"7592019v1.0:2782705v1.0","context":"OCG","contextVersion":"1","ObjectClass":{"publicId":"7592019","version":"1","preferredName":"Mesothelioma","preferredDefinition":"A usually malignant and aggressive neoplasm of the mesothelium which is often associated with exposure to asbestos.","longName":"C3234","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mesothelioma","conceptCode":"C3234","definition":"A usually malignant and aggressive neoplasm of the mesothelium which is often associated with exposure to asbestos.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD3496FC-8BE2-0ED7-E053-4EBD850AF5D7","latestVersionIndicator":"Yes","beginDate":"2021-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-10","modifiedBy":"ONEDATA","dateModified":"2021-03-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2782705","version":"1","preferredName":"Pathologic Finding","preferredDefinition":"Caused by or altered by or manifesting disease or pathology.:The result of an examination or inquiry.","longName":"C25610:C61036","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Investigation Finding","conceptCode":"C61036","definition":"The result of an examination or inquiry.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"56927A70-C1E1-335D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-10","endDate":null,"createdBy":"UMLLOADER_CATISSUE","dateCreated":"2008-09-10","modifiedBy":"ONEDATA","dateModified":"2008-09-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD34B1C0-07B3-3317-E053-4EBD850A241E","latestVersionIndicator":"Yes","beginDate":"2021-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-10","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeDescription":"Created for HCMI: Mesothelioma Curation Request 2.25.2021 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7595756","version":"1","preferredName":"Mesothelioma Pathologic Finding Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"7595756v1.0","context":"OCG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other (specify)","valueDescription":"Specify Other","ValueMeaning":{"publicId":"6782229","version":"1","preferredName":"Specify Other","longName":"6782229","preferredDefinition":"A directive to indicate a response not listed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify Other","conceptCode":"C157106","definition":"A directive to indicate a response not listed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B4B4921-90A3-4044-E053-F662850ADEE5","latestVersionIndicator":"Yes","beginDate":"2019-06-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-14","modifiedBy":"TSESU","dateModified":"2022-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BD5FEB18-8C69-55F0-E053-4EBD850AFB30","beginDate":"2021-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-15","modifiedBy":"ONEDATA","dateModified":"2021-03-15","deletedIndicator":"No"},{"value":"Inflammation (specify)","valueDescription":"Specify Inflammation","ValueMeaning":{"publicId":"7595757","version":"1","preferredName":"Specify Inflammation","longName":"7595757","preferredDefinition":"Be specific about something; define clearly.: A finding of a localized protective response resulting from injury or destruction of tissues. Inflammation serves to destroy, dilute, or wall off both the injurious agent and the injured tissue. In the acute phase, inflammation is characterized by the signs of pain, heat, redness, swelling, and loss of function. Histologically, inflammation involves a complex series of events, including dilatation of arterioles, capillaries, and venules, with increased permeability and blood flow; exudation of fluids, including plasma proteins; and leukocyte migration into the site of inflammation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Inflammation","conceptCode":"C3137","definition":"A finding of a localized protective response resulting from injury or destruction of tissues. Inflammation serves to destroy, dilute, or wall off both the injurious agent and the injured tissue. In the acute phase, inflammation is characterized by the signs of pain, heat, redness, swelling, and loss of function. Histologically, inflammation involves a complex series of events, including dilatation of arterioles, capillaries, and venules, with increased permeability and blood flow; exudation of fluids, including plasma proteins; and leukocyte migration into the site of inflammation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD5FEB18-8C76-55F0-E053-4EBD850AFB30","latestVersionIndicator":"Yes","beginDate":"2021-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-15","modifiedBy":"ONEDATA","dateModified":"2021-03-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BD5FEB18-8C8F-55F0-E053-4EBD850AFB30","beginDate":"2021-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-15","modifiedBy":"ONEDATA","dateModified":"2021-03-15","deletedIndicator":"No"},{"value":"Pulmonary interstitial fibrosis","valueDescription":"Pulmonary Fibrosis","ValueMeaning":{"publicId":"2946061","version":"1","preferredName":"Pulmonary Fibrosis","longName":"2946061","preferredDefinition":"Chronic progressive interstitial lung disorder characterized by the replacement of the lung tissue by connective tissue, leading to progressive dyspnea, respiratory failure, or right heart failure. Causes include chronic inflammatory processes, exposure to environmental irritants, radiation therapy, autoimmune disorders, certain drugs, or it may be idiopathic (no identifiable cause).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pulmonary Fibrosis","conceptCode":"C26869","definition":"Chronic progressive interstitial lung disorder characterized by the replacement of the lung tissue by connective tissue, leading to progressive dyspnea, respiratory failure, or right heart failure. Causes include chronic inflammatory processes, exposure to environmental irritants, radiation therapy, autoimmune disorders, certain drugs, or it may be idiopathic (no identifiable cause).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746AE5AE-64F0-370C-E040-BB89AD4351E3","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BD5FEB18-8CA3-55F0-E053-4EBD850AFB30","beginDate":"2021-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-15","modifiedBy":"ONEDATA","dateModified":"2021-03-15","deletedIndicator":"No"},{"value":"Pleural plaque","valueDescription":"Pleural Plaque","ValueMeaning":{"publicId":"7595758","version":"1","preferredName":"Pleural Plaque","longName":"7595758","preferredDefinition":"Of or pertaining to the pleura.: Abnormal tissue that results from the progressive accumulation or deposit of certain substances in a body cavity, surface, or lumen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pleural","conceptCode":"C25223","definition":"Of or pertaining to the pleura.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Plaque","conceptCode":"C95603","definition":"Abnormal tissue that results from the progressive accumulation or deposit of certain substances in a body cavity, surface, or lumen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD5FEB18-8CB1-55F0-E053-4EBD850AFB30","latestVersionIndicator":"Yes","beginDate":"2021-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-15","modifiedBy":"ONEDATA","dateModified":"2021-03-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BD5FEB18-8CCA-55F0-E053-4EBD850AFB30","beginDate":"2021-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-15","modifiedBy":"ONEDATA","dateModified":"2021-03-15","deletedIndicator":"No"},{"value":"Asbestos bodies","valueDescription":"Asbestos Body","ValueMeaning":{"publicId":"7595760","version":"1","preferredName":"Asbestos Body","longName":"7595760","preferredDefinition":"No Value Exists","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Asbestos Body","conceptCode":"C36015","definition":"No Value Exists","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD5FEB18-8CD7-55F0-E053-4EBD850AFB30","latestVersionIndicator":"Yes","beginDate":"2021-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-15","modifiedBy":"ONEDATA","dateModified":"2021-03-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BD5FEB18-8CF0-55F0-E053-4EBD850AFB30","beginDate":"2021-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-15","modifiedBy":"ONEDATA","dateModified":"2021-03-15","deletedIndicator":"No"},{"value":"None identified","valueDescription":"None Identified","ValueMeaning":{"publicId":"6690571","version":"1","preferredName":"None Identified","longName":"6690571","preferredDefinition":"Nothing was identified.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None Identified","conceptCode":"C157432","definition":"Nothing was identified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86461630-38FC-6318-E053-F662850A9706","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"ONEDATA","dateModified":"2019-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BD5FEB18-8CFA-55F0-E053-4EBD850AFB30","beginDate":"2021-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-15","modifiedBy":"ONEDATA","dateModified":"2021-03-15","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD5FEB18-8C47-55F0-E053-4EBD850AFB30","latestVersionIndicator":"Yes","beginDate":"2021-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-15","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeDescription":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5806857","version":"1","longName":"HCMI (Human Cancer Models Initiative)","context":"OCG","ClassificationSchemeItems":[{"publicId":"7589447","version":"1","longName":"Mesothelioma","context":"OCG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Additional pathologic findings","type":"Preferred Question Text","description":"Additional pathologic findings","url":null,"context":"OCG"}],"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD984C2B-B0E5-7256-E053-4EBD850A624D","latestVersionIndicator":"Yes","beginDate":"2021-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-15","modifiedBy":"COOPERM","dateModified":"2021-03-24","changeDescription":"Created for HCMI: Mesothelioma Curation Request 2/25/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}